Skip to main content
S 854 119th Congress Senate Health Accounting and auditing Advisory bodies Biological and life sciences Congressional oversight Employee performance Federal officials Government employee pay, benefits, personnel management Government ethics and transparency, public corruption Government information and archives Government studies and investigations Infectious and parasitic diseases Public contracts and procurement Research administration and funding

Risky Research Review Act

Introduced: March 5, 2025 Introduced by: Paul, Rand Republican · Kentucky See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 17, 2025
Placed on Senate Legislative Calendar under General Orders. Calendar No. 164.
Sep 17, 2025
Committee on Homeland Security and Governmental Affairs. Reported by Senator Paul without amendment. Without written report.
Jul 30, 2025
Committee on Homeland Security and Governmental Affairs. Ordered to be reported without amendment favorably.
Mar 5, 2025
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Mar 5, 2025
Introduced in Senate
 Plain-English summary Congressional Research Service

Risky Research Review Act

This bill establishes the Life Sciences Research Security Board to oversee the award of federal funding for high-risk life sciences research. High-risk life sciences research means the study of an organism, virus, or related product that could be misapplied to pose a significant threat to the public or could enhance the transmissibility or virulence of certain high-risk pathogens (e.g., Ebola).

Specifically, the bill establishes the board as an independent agency that must review proposed high-risk life sciences research, determine whether a federal agency may award funding for the research, and determine minimum required controls for funded research. Entities that are seeking federal funding must attest to whether their research is high-risk life sciences research. Agencies must certify the validity of these attestations and submit proposed high-risk life sciences research to the board. Agencies must also notify the board of intended awards for other life sciences research for potential review. 

In making its determinations, the board must consider specified factors, including whether the benefits of the research outweigh the risks. The bill prohibits agencies from awarding federal funding for high-risk life sciences research without approval of the board or for life sciences research currently under board review. The board may also review awards that were made before the bill’s enactment.

Entities that fail to properly attest to the nature of their research may lose their eligibility for funding. Additionally, agency employees who fail to comply with the bill's requirements are subject to disciplinary action.

What's happening now September 17, 2025

Placed on Senate Legislative Calendar under General Orders. Calendar No. 164.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Democratic 1